
Keytrox SL 500mg/250mg Injection
Marketer
Healthkey Lifescience Pvt. Ltd.
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Keytrox SL 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; complete the prescribed regimen, even with symptom improvement, to maximize efficacy. Premature cessation can compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications, and pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Your physician may order blood tests and imaging to monitor treatment response.
Uses of Keytrox SL 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Keytrox SL 500mg/250mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
Common Side effects of Keytrox SL 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Keytrox SL 500mg/250mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strongly discouraged.
How Keytrox SL 500mg/250mg Injection works:
Keytrox SL injection, containing 500mg Ceftriaxone and 250mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. The inclusion of Sulbactam, a beta-lactamase inhibitor, safeguards Ceftriaxone's effectiveness by neutralizing bacterial enzymes that would otherwise deactivate it.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Keytrox SL 500mg/250mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Keytrox SL 500mg/250mg Injection is typically considered safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Keytrox SL 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Keytrox SL 500mg/250mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Keytrox SL 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Keytrox SL 500mg/250mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Keytrox SL 500mg/250mg Injection is unnecessary in individuals exhibiting mild or moderate liver dysfunction.
What if you forget to take Keytrox SL 500mg/250mg Injection :
Omitting a scheduled Keytrox SL 500mg/250mg Injection necessitates contacting your physician.
Facts to Know About Keytrox SL 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
